Quote:
"So show me the previous skills in the current
Quote:
"So show me the previous skills in the current management team that has the capabilities to to spot and choose a sales leader , develop a sales program , and most importantly , build a first class sales team with relationships required to penetrate the markets they need to be in. You yourself are saying it’s difficult and I agree. I have built a sales organization from scratch. It takes a long time to get them Up to speed and be highly affective."
Current management doesn't need the skills to run a big pharma. They need the skills to get a few approvals and the wisdom to know when to walk away wealthy. Often problematic in its own right. I've never known a company where there wasn't a discussion of management issues at one time or another. Probably are some, but Apple certainly wasn't one of them and that turned out ok. Going from a pre-rev OTC to a Fortune 500 is a hell of a bumpy road for most any company and if CYDY is heading in that direction they will encounter plenty of potholes in that road. To expect less is not very realistic. If at some point the road is just too bumpy for some passengers they will choose to get out. Hopefully they will do so with a fat brokerage account. In addition, becoming a BP is not an issue right now. Approvals and revenue are the issues and good CD-12 data will likely solve both. I think current management is quite capable of bringing us good data, perhaps they have accomplished it already and we just don't know about it yet. Besides, I've placed my bet, my chips are on the table and I have no intention of pulling them back at this time. To mix another metaphor I got on this horse knowing full well it was likely to buck some, maybe even throw me off and at my age I don't bounce as well as I used to, but it appears to be one hell of a horse and I'm expecting one hell of rewarding ride. If I do get bucked off it my own fault for get on the damn thing knowing it could buck. The horse is just being a horse.
6
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...
Continue Reading
Top 5 Most Recently Viewed Articles
Kia Showcases Bold Innovations at SEMA 2024 Kia is back at SEMA, presenting a series of extraordinary concepts that redefine the automotive landscape. Enthusiasts and industry professionals alike have gathered to witness the creativity and innovation that the company has brought to this renowned automotive event. Innovation and Creativity on Display This year, Kia has...
Continue Reading
Home Prices Continue to Show Resilience In recent analysis, the latest findings reveal a modest yet noteworthy 0.5% increase in home prices across the U.S. for November, marking the third month in a row with this consistent rise. This stability reflects a steady approach in a market that has seen significant fluctuations in the past couple of years. Year-Over-Year Trends...
Continue Reading
Innovative Progress in Colorectal Cancer Testing Exact Sciences Corp. (NASDAQ: EXAS) has recently made significant strides in the detection of molecular residual disease (MRD) through its Oncodetect test. This innovative solution is gaining attention for its ability to identify traces of cancer cells, a critical factor in improving patient outcomes following surgical...
Continue Reading
Revolutionizing Banking with Bitcoin Infrastructure El Salvador is making headlines as it embarks on an ambitious journey to integrate Bitcoin into its financial framework. The government is working on establishing banks fundamentals that focus entirely on the cryptocurrency. This initiative, backed by the country’s Bitcoin Office, is poised to create "Bitcoin Banks,"...
Continue Reading
Cryptoweb3 Celebrates Major Award at Renowned Summit Recently, the European digital currency trading platform Cryptoweb3 received the prestigious "Most Promising Exchange of the Year" award during the Global Blockchain Summit. This event is a significant gathering for blockchain industry enthusiasts worldwide, featuring experts, investors, and innovative companies....
Continue Reading